Award ceremony: Jung Foundation for Science and Research focuses on supporting promising scientific young talents in 2024

Dr Maximilian U. Friedrich and Dr Christine Maria Poch receive Jung Career Advancement Award; Prof. Rudolf Zechner receives Jung Gold Medal for Medicine 

Hamburg, 2nd May 2024. The Hamburg-based Jung Foundation for Science and Research will for the first time be awarding two Jung Career Advancement Awards for Medical Research in 2024. This highlights its current focus on supporting promising scientific young talents – a focus that it already set back in 2023 by awarding five scholarships to doctoral students and by launching a new call for applications for a fellowship in medical history. This year’s Jung Career Advancement Award is going to cardiologist Dr Christine Maria Poch as well as neurologist Dr Maximilian U. Friedrich. Both will receive the full funding of €210,000. A key component of the foundation’s work is honouring outstanding research that has successfully advanced human medicine. For this reason, the Jung Foundation has decided to also award the Jung Gold Medal for Medicine this year as recognition of a life’s work. The recipient is Professor Rudolf Zechner, with the prize giving him the opportunity to award a scholarship of €30,000 to a junior scientist of his choice. The laureates will be honoured at a festive award ceremony dinner with the invited Jung family at the Anglo-German Club in Hamburg on 2nd May 2024.

Here you can find the press release for download.

Here you can find the pictures for download.

 

Zur Pressmitteilung

Outstanding research work in the medical field

Stefan Rose-John receives the 2023 Jung Gold Medal for Medicine for his life’s work in translational medicine

 

Hamburg, 4 May 2023. “The human body is an incredibly complex machine, and I was privileged to be involved in researching the biochemistry of the human immune system.” What intelligence agencies do at a large scale, biochemists research on a small scale – the decoding of communication. The latter focuses on examining the exchange of information between the body’s cells. And it is precisely in this area that Professor Stefan Rose-John has been working for a long period of time, most recently at the Biochemical Institute in the Faculty of Medicine at the University of Kiel – with a vast amount of curiosity and passion. Through the work he has carried out over the course of his career, he has provided a great service to medicine and paved the way for new medications and treatments. He not only succeeded in discovering a new signalling pathway of the interleukin-6 (IL-6) cytokine, but also in finding ways to inhibit this pro-inflammatory pathway without compromising the protective and regenerative properties of IL-6. The Jung Foundation for Science and Research is now recognising this work by awarding him the Jung Gold Medal for Medicine. Each year, the Jung Foundation gives this award to leading researchers who have made a significant contribution to the advancement of medical research and practice or who are still actively doing so. The award is a recognition of their lifetime achievements to date.

Hier finden Sie die Pressemitteilung zum Download.

Das Bildmaterial stellen wir Ihnen gern hier zur Verfügung.

 

Zur Pressmitteilung

Developing tailored medications with mRNA technology

Özlem Türeci receives the 2023 Jung Prize for Medicine for her research into the prevention and treatment of tumour diseases, infectious diseases and other serious illnesses

 

Hamburg, 4 May 2023. The potential of mRNA vaccines is shaping scientific discourse today in many ways. Having helped to alleviate the effects of the COVID-19 pandemic, this potential has now become widely known. However, the fundamental and translational research as well as the development of mRNA technology that enabled the fast response, development and thus rapid availability of a vaccine against COVID-19 began decades ago. As co-founder of BioNTech, Professor Özlem Türeci is a leader in this field. Her research in immunology and mRNA technology also highlights development potential beyond COVID-19 for the prevention and treatment of tumour diseases, infectious diseases and other serious illnesses. In recognition of her achievements, she receives the Jung Prize for Medicine, which is endowed with a total of 300,000 euros, from the Jung Foundation for Science and Research. Türeci can use the prize fund for her future research as she sees fit. The Jung Prize for Medicine has been awarded since 1976 and recognises the work of researchers who have made a significant contribution to the advancement of human medicine and whose work promises to continue to do so in the future. It is one of the most highly endowed medical awards in Europe.

Hier finden Sie die Pressemitteilung zum Download.

Das Bildmaterial stellen wir Ihnen gern hier zur Verfügung.

 

Zur Pressmitteilung

Gaining a better understanding of epilepsy and migraine: exploring possible treatment approaches

Achmed Mrestani receives the 2023 Jung Career Advancement Award for his research project on understanding the pathophysiology of neurological calcium channel defects

 

Hamburg, 4 May 2023. Epilepsy and migraine are some of the most common neurological disorders. “The two disorders show significant genetic overlap,” explains Achmed Mrestani, MD, physician in training at the Clinic and Polyclinic for Neurology at University of Leipzig Medical Center and a researcher at the Faculty of Medicine at the University of Leipzig. In part, they originate through a dysfunction of voltage-gated P/Q-type calcium channels caused by point mutations. But how does this affect the architecture of synapses? And what structural and functional changes occur as result of these point mutations? This is where Achmed Mrestani’s current research project comes in. He hopes that this will lead to new potential treatments that, in the best-case scenario, can intervene specifically in the molecular interactions within the active zone. To support this exciting work, the Jung Foundation for Science and Research is awarding Achmed Mrestani with the Jung Career Advancement Award, which is endowed with 210,000 euros. The financial support will be provided over the next three years and can be used as he sees fit to conduct his own research project. The Jung Career Advancement Award is specifically aimed at young researchers and is the only award offered by the Jung Foundation for Science and Research for which people can submit applications.

Hier finden Sie die Pressemitteilung zum Download.

Das Bildmaterial stellen wir Ihnen gern hier zur Verfügung.

 

Zur Pressmitteilung

The Jung Foundation for Science and Research awards the 2023 Jung Prize for Medicine to Özlem Türeci

Stefan Rose-John receives a prize for his life’s work and Achmed Mrestani is awarded as young researcher

 

Hamburg, 4 May 2023. New treatments against cancer, autoimmune diseases, migraine and epilepsy – these are some of the areas covered by the research results of this year’s award winners from the Jung Foundation for Science and Research. With their groundbreaking work, Professor Özlem Türeci, Professor Stefan Rose-John and Dr Achmed Mrestani have made a significant contribution to alleviating the suffering of patients in the future. They will be honoured for this work by the Jung Foundation for Science and Research at an awards ceremony held on 4 May at the Anglo-German Club in Hamburg. With the Jung Prize for Medicine, the Jung Gold Medal for Medicine and the Jung Career Advancement Award, the Jung Foundation presents three awards every year to recognise cutting-edge medical work undertaken by outstanding physicians and researchers. With a total sum of 540,000 euros, they are among the most highly endowed medical awards in Europe.

Hier finden Sie die Pressemitteilung zum Download.

Das Bildmaterial stellen wir Ihnen gern hier zur Verfügung.

 

Zur Pressmitteilung

Jung Foundation offers a forum for renowned researchers: 3rd Jung Symposium with Türeci, Rose-John and Mrestani at the UKE and via live stream on 5 May 2023

Hamburg, 11/04/2023. What possibilities do mRNA agents open up for future cancer treatments? How can autoimmune diseases be combated with greater precision? And how do point mutations in the CACNA1A gene influence the onset of epilepsy and migraines? The 3rd Jung Symposium “Excellent medicine 2023” is the place to be for anyone who is intrigued by these questions. Here, the Jung Foundation for Science and Research will be unveiling the outstanding research findings of this year’s laureates. Attendees can look forward to talks by the doctor, immunologist and cancer researcher Prof. Dr. med. Dr. h.c. mult. Özlem Türeci, the translational neuroscientist Prof. Dr. rer. nat. Stefan Rose-John and young researcher Dr. med. Achmed Mrestani. The 3rd Jung Symposium will be broadcast live via video stream from 1 p.m. to 4 p.m. on 5 May 2023 and can either be watched online or attended in person at the Ian K. Karan auditorium of the University Medical Center Hamburg-Eppendorf (UKE). Interested parties will find the current programme and all key information at https://jung-stiftung.de/en/symposium-2023-en/. Attendance is free of charge.

You can find the press release for download here.

You can find the picture for download here.

 

Zur Pressmitteilung

Jung Foundation for Science and Research provides funding for projects run by the Neuengamme Concentration Camp Memorial as well as Médecins Sans Frontières

 

Study draws ambivalent conclusion about Ernst Jung – foundation faces up to responsibility and and initiates comprehensive measures

Supplement to the press release dated February 22, 2023 – Hamburg, Dezember 2023. The Jung Foundation for Science and Research is supporting the Neuengamme Concentration Camp Memorial and Médecins Sans Frontières (MSF) with funding totaling 777,000 euros. These projects are part of a comprehensive package of measures adopted by the Jung Foundation at the beginning of 2023 in response to the results of a study the Foundation itself initiated on its founder Ernst Jung and his companies during the National Socialist era. In doing so, it aims to face up to Ernst Jung’s history, assume lasting responsibility, contribute to the further investigation of the National Socialism period, actively educate people and help those in need.

Further information on the background to these measures can be found in the original press release dated February 22, 2023 including the update below.

You can find the press release with update for download here.

You can find the picture for download here.

 

Zur Pressmitteilung

Strong women in the Board of Trustees of the Hamburg Jung Foundation

 

Hamburg, 24. October 2022. Combined scientific and economic know-how: Since June, Professor Dr Blanche Schwappach-Pignataro, Dean of the Medical Faculty Hamburg, has been a member of the Scientific Advisory Board and Board of Trustees of the Hamburg Jung Foundation for Science and Research. This means that the respected molecular biologist is now the second woman on the foundation’s Board of Trustees, alongside Petra Scharner-Wolff, Chief Financial Officer of the Hamburg Otto Group.

You can download the full press release here.

 

Zur Pressmitteilung